You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Radiopharmaceuticals

Showing 1 - 25 of 204
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Amyloidosis Transthyretin Trial in Caen, Lille (Whole-body & CZT bone tracer imaging (SPECT))

Recruiting
  • Amyloidosis Transthyretin
  • Whole-body & CZT bone tracer imaging (SPECT)
  • Caen, France
  • +1 more
Mar 8, 2022

Distinguishing Between Alzheimer's Disease, Lewy Body Dementia,

Recruiting
  • Alzheimer's Disease
  • +2 more
  • DaTscan
  • +5 more
  • Columbus, Ohio
    The Ohio State University
Sep 23, 2022

Neurodegenerative Disease Trial in Philadelphia ([18F]T807)

Recruiting
  • Neurodegenerative Disease
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Mar 24, 2022

Alzheimer Trial in Saint Louis ([18F]RO-948, 18F-MK6240, 18F-GTP1)

Recruiting
  • Alzheimer Disease
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 14, 2022

Mild Cognitive Impairment, Healthy, Alzheimer Trial in Schlieren (18F-AV-1451 (Tau-PET tracer))

Active, not recruiting
  • Mild Cognitive Impairment
  • +3 more
  • 18F-AV-1451 (Tau-PET tracer)
  • Schlieren, Zurich, Switzerland
    Institute for Regenerative Medicine (IREM)
Dec 21, 2021

Exposure, Radiation Trial in Vandoeuvre-les-Nancy (Training in the use of the automaton)

Not yet recruiting
  • Exposure, Radiation
  • Training in the use of the automaton
  • Vandoeuvre-les-Nancy, France
    CHRU Nancy - Brabois
Aug 4, 2021

Prostate Cancer, Prostate Cancer Metastatic, Prostatic Tumor Trial in Vancouver (18F-DCFPyL PET/CT scan, Placebo drink, MSG

Completed
Has Results
  • Prostate Cancer
  • +2 more
  • 18F-DCFPyL PET/CT scan
  • +2 more
  • Vancouver, British Columbia, Canada
    BC Cancer
Nov 15, 2021

Cardiac Amyloidosis Trial in Cleveland (F-18 florbetapir)

Terminated
Has Results
  • Cardiac Amyloidosis
  • F-18 florbetapir
  • Cleveland, Ohio
    Cleveland Clinic Foundation (Main Campus)
Jul 7, 2021

University of Pittsburgh Brain Health Initiative

Recruiting
  • Traumatic Brain Injury
  • Cognitive/Neuropsychological Testing
  • +10 more
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Department of Neurosurgery
Dec 3, 2021

Cancer Diagnosis, Diagnostic Techniques and Procedures, Diagnostic Imaging Trial in Palo Alto (F-18 FDG, Ga-68-DOTA-TATE,

Completed
Has Results
  • Cancer Diagnosis
  • +2 more
  • F-18 FDG
  • +3 more
  • Palo Alto, California
    Stanford University, School of Medicine
Apr 8, 2021

Validation of Online Cognitive Testing Trial in San Francisco (Validation Study)

Completed
  • Validation of Online Cognitive Testing
  • Validation Study
  • San Francisco, California
    BrainHealthRegistry.org
Mar 29, 2021

Postoperative Cognitive Dysfunction Trial in San Francisco (Florbetapir F 18 (18F-AV-45), no intervention)

Recruiting
  • Postoperative Cognitive Dysfunction
  • Florbetapir F 18 (18F-AV-45)
  • no intervention
  • San Francisco, California
    San Francisco VA Medical Center
Jul 6, 2021

Cognition Disorders Trial in United States (18F-AV-1451)

Active, not recruiting
  • Cognition Disorders
  • Phoenix, Arizona
  • +6 more
Aug 3, 2021

Alzheimer's Disease (AD) and Related Disorders Trial in France (Flutemetamol (18F), Florbetapir (18F))

Completed
  • Alzheimer's Disease (AD) and Related Disorders
  • Flutemetamol (18F)
  • Florbetapir (18F)
  • Angers, France
  • +25 more
Feb 2, 2022

Alzheimers Disease, Dementia, Alzheimers Disease, Familial Trial in Worldwide (Gantenerumab, Solanezumab, Matching Placebo

Completed
Has Results
  • Alzheimers Disease
  • +2 more
  • Birmingham, Alabama
  • +24 more
Aug 25, 2022

Alzheimer, Mild Cognitive Impairment, Progressive Supranuclear Palsy Trial in Berkeley (Radiopharmaceuticals)

Unknown status
  • Alzheimer Disease
  • +2 more
  • Radiopharmaceuticals
  • Berkeley, California
    University of California, Berkeley
Mar 23, 2020

Alzheimer Trial in Canada, United States (18F-Flortaucipir radiopharmaceutical, 18F-MK-6240 radiopharmaceutical, Amyloid-ß

Recruiting
  • Alzheimer Disease
  • 18F-Flortaucipir radiopharmaceutical
  • +2 more
  • Berkeley, California
  • +7 more
Jan 23, 2023

Healthy, Alzheimer Trial in Baltimore ([F18]RO-948, [F18]MK-6240, [F18]AV1451)

Withdrawn
  • Healthy
  • Alzheimer Disease
  • [F18]RO-948
  • +2 more
  • Baltimore, Maryland
    John Hopkins Hospital
Feb 7, 2020

Neuroendocrine Tumors Trial in Innsbruck, Kraków, Ljubljana ([99mTc]Tc-TECANT1)

Recruiting
  • Neuroendocrine Tumors
  • Innsbruck, Austria
  • +2 more
May 12, 2023

Diagnostic Agent Adverse Reaction, Radiation Exposure Trial in New Haven (18F-LY3950321, PET Scan)

Recruiting
  • Diagnostic Agent Adverse Reaction
  • Radiation Exposure
  • New Haven, Connecticut
    Invicro, LLC
Mar 20, 2023

Patients With Metastatic Castration-resistant Prostate Cancer Trial (177Lu-PSMA-617 PET scan)

Not yet recruiting
  • Patients With Metastatic Castration-resistant Prostate Cancer
  • 177Lu-PSMA-617 PET scan
  • (no location specified)
Nov 13, 2023

Alzheimers Disease, Dementia, Alzheimers Disease, Familial Trial in Worldwide (Gantenerumab, Solanezumab, Matching Placebo

Recruiting
  • Alzheimers Disease
  • +2 more
  • Birmingham, Alabama
  • +38 more
Nov 1, 2021

Neuroblastoma Trial in United States (18F-MFBG)

Recruiting
  • Neuroblastoma
  • Los Angeles, California
  • +7 more
Aug 18, 2022

Gastrointestinal Cancer Trial in Beijing (Intravenous injection of 68Ga-PMD22)

Recruiting
  • Gastrointestinal Cancer
  • Intravenous injection of 68Ga-PMD22
  • Beijing, China
    Peking Union Medical College Hospital, Chinese Academy of Medica
Jun 30, 2023

Aldosterone-Producing Adenoma Trial in Chengdu ([18F]AlF-NOTA-pentixather PET/CT)

Recruiting
  • Aldosterone-Producing Adenoma
  • [18F]AlF-NOTA-pentixather PET/CT
  • Chengdu, Sichuan, China
    Sichuan Academy of Medical Sciences.Sichuan Provincial People's
Apr 3, 2023